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Highlights 
? This is the first study to explore the psychometric properties of the OASIS and ODSIS, 
screening tools for anxiety and mood disorders, in a Spanish sample of patients diagnosed with 
emotional disorders in a specialized mental health setting. 
? The OASIS and ODSIS are easily administered screening tools with an excellent internal 
consistency, favorable convergent and discriminant validity, and good sensitivity to 
therapeutic change.  
? A cut-off point of 10 for both instruments results in the best rate of correct clinical/nonclinical 
classifications. 
? The Spanish adaptations of the OASIS and the ODSIS demonstrated their cross-cultural utility. 
? The OASIS and ODSIS should make screening of anxiety and depressive symptoms in public 
health settings more feasible and could facilitate adequate referrals and routine evaluation. 
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Abstract 
Background: Anxiety and depressive disorders are the most frequent disorders for which patients seek care in 
public health settings in Spain.  This study aimed at validating the Overall Anxiety Severity and Impairment 
Scale (OASIS) and the Overall Depression Severity and Impairment Scale (ODSIS), which are brief screening 
scales for anxiety and depression consisting of only five items each. 
Methods: The study was conducted in a Spanish clinical sample receiving outpatient mental health treatment (N 
= 339). A subsample of participants (n = 219) was assessed before and after receiving a course of cognitive-
behavioral treatment. 
Results: The results revealed excellent internal consistency estimates (Cronbach’s alpha for the OASIS and the 
ODSIS was .87 and .94, respectively), along with promising convergent and discriminant validity and test-
criterion relationships (i.e., moderate correlation with other measures of depression and anxiety, as well as with 
neuroticism, quality of life, adjustment, and negative affect). A one-dimensional structure was obtained for the 
OASIS and the ODSIS. The ROC analyses indicated an area under the curve of .83 for the OASIS and the 
ODSIS when predicting moderate-to-severe anxiety and depression, respectively.  Good sensitivity to 
therapeutic change was also evidence and the analysis of the sensitivity as a function of 1-specificity area 
suggested a cutoff value of 10 for both scales. 
Limitations: Inter-rater reliability of diagnoses with the ADIS-IV interview could not be investigated and the 
results obtained may not be generalizable to other samples and health settings. 
Conclusions: The availability of these two short and psychometrically sound measures should make screening of 
anxiety and depressive symptoms in routine care more feasible. 
Key words: anxiety; depression; transdiagnostic; screening; validation; psychometric properties. 
 
 
 
Introduction 
Anxiety and depressive disorders, also known as emotional disorders (EDs; Barlow, 1991) are 
common conditions that negatively impact functioning (Campbell-Sills et al., 2009). According to the 
World Health Organization (WHO), in Spain alone, anxiety and depressive disorders affect nearly 2 
million and 2.5 million people, respectively, which amount to up to 5.2% of the population in the 
country (WHO, 2017). Not surprisingly, EDs are largely prevalent in primary care and specialized 
mental health settings in Spain (Gutiérrez-Fraile et al., 2011; Muñoz-Navarro et al., 2017; Ruiz-
Rodríguez et al., 2017). The present study aims at adapting two short screening tools for anxiety and 
depressive symptoms to be used in Spanish public care. 
Several authors have indicated that diagnosis and monitoring of patients with EDs in Spanish public 
health settings is problematic. For example, a study by Castro-Rodríguez and colleagues (2015) 
suggested that half of the patients with an ED are not correctly diagnosed in primary care. 
Consequently, a large number of individuals with ED are not properly referred to specialized care and 
do not receive the most optimal treatment (Martín Jurado et al., 2012). While there might be several 
factors explaining this, some authors have attributed the previous to healthcare overload, time 
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constraints during consultations, and family physicians’ insufficient familiarity with the assessment 
and treatment of psychiatric disorders (Muñoz-Navarro et al., 2017). . It is important to note that it is 
at this first level of care where correct identification of those who need specialized interventions is of 
paramount importance, so quick and straightforward assessment tools for an early detection of EDs are 
fundamental (Cano Vindel et al., 2012). A similar problem occurs in specialized mental health settings 
in Spain, where limited resources (e.g., reduced number of professionals, especially psychologists) has 
shown to negatively impact the quality of services provided (Gabilondo et al., 2011). An example of 
this is the long waiting lists that currently exist in Spanish public mental health settings, that is, from 
45 to up to 75 days between appointments (Chueca et al., 2003; González et al., 2008). A quick and 
feasible assessment tool for the evaluation of anxiety and depressive symptoms to be used in routine 
care would benefit psychologists and psychiatrists by reducing the time they require for the 
assessment of the patients’ progress through treatment. 
Many self-report screening measures have been designed to assess specific diagnostic categories (e.g., 
Panic Disorder Severity Scale [PDSS]; Shear et al., 2001). Although these scales are useful to 
ascertain whether an individual is likely to meet criteria for a specific disorder, the administration of a 
large number of screening measures (e.g., one for each ED diagnosis) is not feasible in public health 
settings. Thus, transdiagnostic measures that capture the spectrum of ED presentations may be 
particularly useful in such settings (Campbell-Sills et al., 2009). Furthermore, traditional self-report 
measures typically assume that the frequency of symptoms reflects the severity of the disorder, while 
ignoring the key role of functional impairment or distress for diagnosis (Ito et al., 2014).  
The Overall Anxiety Severity and Impairment Scale (OASIS; Norman et al., 2006) and the Overall 
Depression Severity and Impairment Scale (ODSIS; Bentley et al., 2014) were developed in response 
to the limitations of existing screening tools. Both instruments were designed to assess transdiagnostic 
symptoms and functioning associated with anxiety and depressive disorders, respectively. The OASIS 
and the ODSIS have five items each and can be administered in only 2-3 minutes. Both measures have 
been shown to be useful in the assessment of patients’ progress through treatment (Barlow et al., 2017; 
Norman et al., 2013; Osma et al., 2015). The OASIS has been validated into English (Norman et al., 
2006), Japanese (Ito et al., 2014), and Dutch (Hermans et al., 2014). An online version of this measure 
has also been recently been validated into Spanish in a sample of individuals with milder depression 
and anxiety (González-Robles et al., 2018). A single-factor model including all items has been 
replicated across investigations (Bragdon et al., 2016; Campbell-Sills et al., 2009; González-Robles et 
al., 2018; Hermans et al., 2014; Ito et al., 2014; Moore et al., 2015; Norman et al., 2013; Norman et 
al., 2011; Norman et al., 2006) and a good internal consistency (i.e., between .80 and .94) has been 
reported (Hermans et al., 2014; Ito et al., 2014; Norman et al., 2006).   
The cut-off points for the OASIS have ranged from 5 to 10 in clinical samples (Bragdon et al., 2016; 
Campbell-Sills et al., 2009; González-Robles et al., 2018; Hermans et al., 2014; Moore et al., 2015; 
Norman et al., 2013) and from 8 to 9 in studies with clinical and non-clinical populations altogether 
(Ito et al, 2014; Norman et al., 2011). 
Similar to the OASIS, the ODSIS has been validated into English (Bentley et al., 2014) and Japanese 
(Ito et al., 2015). A single-factor solution has been proposed for the ODSIS and internal consistency 
findings have been excellent (Bentley et al, 2014; Ito et al., 2015). The cutoff points for the ODSIS 
have ranged from between 7 and 11 with clinical and non-clinical samples altogether (Bentley et al., 
2014; Ito et al., 2015).  
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The present study goal was to replicate and extend prior research on the psychometric properties of the 
OASIS and the ODSIS in a Spanish outpatient sample of mental health patients with EDs. 
Specifically, we aimed at replicating the findings of the validations conducted in the USA, the 
Netherlands, Spain, and Japan, thus providing further evidence for the transcultural validity of these 
scales. The study also had a novel goal, that is, to determine the sensitivity of both measures to 
therapeutic change after a transdiagnostic, cognitive-behavioral treatment for EDs, namely, the 
Unified Protocol (Barlow et al., 2017; Blind note). 
The following hypotheses were proposed: 1) for both scales, a one-dimensional structure will be 
replicated; 2) an acceptable internal consistency will be obtained; 3) convergent and discriminant 
validity will be established through significant positive correlations between the OASIS and the 
ODSIS and measures assessing similar constructs, as well as weaker correlations with measures of 
different constructs; 4) the ROC curve will reveal an optimal cut-off point of approximately 10 for 
both measures; and finally, 5) adequate sensitivity to therapeutic change will be indicated by 
significant and positive correlations between the change detected by the reference measurements (the 
Beck Anxiety Inventory and Beck Depression Inventory-II) and the change detected by the OASIS 
and the ODSIS. 
Method 
Participants 
Participants were drawn from a large effectiveness trial of the Unified Protocol (UP) in the Spanish 
public mental health system (Blind note). The sample for the present study was composed of 339 
participants of whom 272 were women (80.2%). Mean age in the sample was 42.63 years (SD = 12.79, 
range = 18-77). Table 1 shows additional socio-demographic characteristics. The selected participants 
adults seeking psychological assistance in the national health system. The sample was obtained in 8 
public mental health centers of Spain after the approval of their respective ethics and research 
committees (for more information, Blind note): Blind note. All participants had a primary ED 
diagnosis. The inclusion criteria to participate in the study were: 1) Principal diagnosis (most 
interfering and severe) of anxiety disorder, mood disorder, adjustment disorder; 2) The patient is over 
18 years of age; 3) The patient is fluent in the language in which therapy is performed (Spanish in the 
present study); 4) The patient is able to attend to the evaluation and treatment sessions and signs the 
informed consent form; 5) Patients taking pharmacological treatment for their emotional disorder are 
asked to maintain the same dosages and medications for at least 3 months prior to enrolling in the 
study and during the whole treatment. The exclusion criteria were: 1) The patient presents a severe 
condition that would require to be prioritized for treatment, so that an interaction between both 
interventions cannot be ruled out. These include a severe mental disorder (bipolar disorder, 
schizophrenia, or an organic mental disorder), suicide risk at the time of assessment, or substance use 
in the last three months (excluding cannabis, coffee, and / or nicotine); 2) The patient has previously 
received 8 or more sessions of psychological treatment with clear and identifiable CBT principles 
within the past 5 years. 
From the total sample (N = 339), we extracted the subsample of 219 participants who completed two 
assessments (one before psychological treatment onset and the other at the end of treatment) to assess 
the sensitivity to therapeutic change of the OASIS and the ODSIS. Mean age in the sample was 43.25 
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years (SD = 12.21, range=18-72) and 79.5% of them were women. When comparing those who 
completed both evaluations against participants who only answered to one assessment, we found no 
significant differences in the OASIS (t = .184, p < .366), the ODSIS (t = .210, p < .834), the BAI (t = 
.306, p < .481), and the BDI-II (t = .901, p < .246). 
Procedure 
When seeking care at a Spanish public mental health center, potential participants were evaluated by 
professional specialists (clinical psychologists, psychiatrists, or resident psychologists) with the 
lifetime version of the Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV-L; Brown et al., 
1994) or the Clinical Structured Interview for Axis I Disorders of the Clinical Version of the DSM-IV 
(SCID-I-CV; First et al., 1997). This was done to guarantee the existence of a primary diagnosis of 
ED. We did not use the ADIS-5 because it is not available in Spanish yet. Participants meeting the 
requirements for the primary study (i.e., Blind note) were given information about data confidentiality 
and were asked to provide written informed consent. The same day, they completed the evaluation 
tools in person and on paper and pencil. 
The proposed treatment is a cognitive-behavioral intervention called Unified Protocol for the 
transdiagnostic treatment of emotional disorders (PU; Barlow et al., 2018). The UP focuses on the 
identification of dysfunctional emotion regulation strategies that are common to all emotional 
disorders and helps patients to tolerate and cope with emotions in a more adaptive way (Barlow et al., 
2018). The UP consists of 8 core intervention modules that can easily be delivered in group format 
(Bullis et al., 2015; Osma et al., 2015). For the present study, a 12-session group format was 
conducted in different mental health settings in Spain.  The treatment had a duration of approximately 
three months and patients received a 2-hour session weekly. Both the patient and the therapist manuals 
have been previously translated into Spanish (Barlow et al., 2015) 
Instruments 
Semi-structured Interview Schedule for Anxiety Disorders Lifetime version (ADIS-IV-L; Brown et al., 
1994); translated into Spanish by Botella and Ballester (1997). This semistructured interview evaluates 
anxiety and depressive disorders, as well as somatoform and substance use disorders according to the 
fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; APA, 1994). 
Test-retest reliability of this interview ranges from .67 to .86 (Brown et al., 2001). 
Clinical Structured Interview for Axis I Disorders of the Clinical Version of the DSM-IV (SCID-I-CV; 
First et al., 1997), adapted and validated into Spanish by First et al. (1999). This semi-structured 
interview is used to establish DSM-IV Axis I diagnoses (APA, 1994). The response scale ranges from 
1 (Symptom absent or false) to 3 (True or clinically present). Test-retest reliability varies from .37 to 
1, depending on studies (Rogers, 2001). 
Beck Depression Inventory (BDI-II; Beck et al., 1996), validated into Spanish by Sanz et al. (2003). 
The BDI-II assesses depressive symptoms. It consists of 21 items, each with four different statements 
that reflect an increase in the degree of depression. A score of 0 indicates the absence of depressive 
symptoms and 3 reflects the most severe levels of depression. The scale has a 0-to-63 range. In the 
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Spanish validation with a clinical sample, a Cronbach alpha of .89 was obtained (Sanz et al., 2005). 
Cronbach’s alpha for the BDI-II in the present sample is .917. The cut-off point used is 20, as 
suggested in the literature (Sanz et al., 2003). 
Beck Anxiety Inventory (BAI; Beck & Steer, 1993), validated into Spanish by Sanz and Navarro 
(2003). The BAI is composed of 21 items that evaluate anxiety symptoms. Responses use a 4-point 
Likert scale ranging from 0 (Not at all) to 3 (Severely). The total score can range from 0 to 63. The 
Spanish validation study in a clinical sample revealed a Cronbach alpha of .91 (Sanz et al., 2012). 
Cronbach’s alpha for the BAI in the present sample is .926. The cut-off point used is 16, as 
recommended in previous research (Sanz & Navarro, 2003). 
 
Positive and Negative Affect Scale (PANAS; Watson et al., 1988), validated into Spanish by Sandín et 
al. (1999). The PANAS consists of 20 items that measure both positive and negative affect, with 10 
items for each dimension. Respondents indicate the extent to which they experience different emotions 
representing both dimensions. Items use a 5-point Likert response scale ranging from 1 (Not at all or 
very slightly) to 5 (Extremely). In its Spanish validation, Cronbach alphas between .87 and .91 were 
obtained for both men and women in positive and negative affect (Sandín et al., 1999). In the present 
study, Cronbach’s alpha for the PANAS are .889 for Positive Affect and .893 the Negative Affect. 
 
Quality of Life Index (QLI; Ferrans & Powers, 1985), validated in Spanish by Mezzich et al. (2000). 
This measure is comprised of 10 items, each of which refers to a different dimension of quality of life. 
Each item is evaluated on a 10-point scale ranging from 1 (Bad) to 10 (Excellent). An overall index is 
calculated by summing all items (total range is 10 to 100). In the Spanish validation study (Mezzich et 
al., 2000), the QLI obtained a Cronbach alpha of .89. The Cronbach’s alpha in the present sample is 
.869. 
 
Scale of Maladjustment (SM; Echeburúa et al., 2000). This scale reflects the extent to which people's 
current problems affect different areas of their daily lives, including work or studies, social life, leisure 
time, couple relationship, and day-to-day maladjustment. All items are evaluated on a 6-point response 
scale ranging from 0 (Not at all) to 5 (Very severe). The total score ranges from 0 to 30, and is 
obtained by summing all items. Higher scores indicate poorer adjustment. The scale had excellent test-
retest reliability (r = .86) and an internal consistency of .94 (Echeburúa et al., 2000). The Cronbach’s 
alpha in the present sample is .830. 
 
NEO-Five-Factor Personality Inventory (NEO-FFI; Costa & McCrae, 1999). The NEOFFI consists of 
60 items that provide a quick and general measurement of the Big Five personality dimensions. These 
are neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness. The 
responses are rated on a 5-point Likert scale ranging from 0 (Strongly disagree) to 4 (Strongly agree). 
Each personality dimension is composed of 12 items (scores for each dimension range from 0 to 48). 
The internal consistency of the NEO-FFI dimensions ranges between .82 and .90. Cronbach’s alpha 
values in the present sample are .760 for Neuroticism, .809 for Extraversion, .769 for Opening to the 
Experience, .709 for Agreeableness, and .708 for Conscientiousness. 
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Overall Anxiety Severity and Impairment Scale (OASIS; Norman et al., 2006). The scale presents five 
items. This items are related with the frequency of symptoms (During the last week, did you often feel 
anxious?), their intensity (During the last week, when you felt anxious, to what extent was your anxiety 
intense or severe?), their interference with the person's work or school life (During the last week, to 
what extent did anxiety interfere with your ability to do the things you had to do regarding work, 
school, or your home?), and their interference with social life (During the last week, to what extent 
has anxiety interfered with your social life and your relationships?). All items are rated on a 5-point 
Likert scale ranging from 0 (I didn't feel anxious) to 4 (Constant anxiety). The total scale score, which 
ranges from 0 to 20, is obtained by summing all items. Higher scores are indicative of greater severity 
and functional impairment as a result of anxious symptoms (Norman et al., 2006). For this study, we 
used the Spanish translation of the original scales (Appendix 1), which was carried out by Osma and 
García-Palacios by means of a back translation process. The Spanish version of the OASIS was 
obtained after a backward translation to ensure conceptual equivalency. Forward translation into 
Spanish was carried out by an independent native-speaking translator who was proficient in English. 
The Spanish version was back translated into English by an independent English native translator. No 
significant changes were required to obtain the final version. Cronbach’s alpha for the OASIS in the 
present sample is presented in the results section. 
 
Overall Depression Severity and Impairment Scale (ODSIS; Bentley et al., 2014). Similar to the 
OASIS, the ODSIS includes five items, which are related with the frequency of symptoms (During the 
last week, did you often feel depressed?), their intensity (During the last week, when you felt 
depressed, to what extent was your depression intense or severe?), their interference with the person's 
work or school life (During the last week, to what extent did depression interfere with your ability to 
do the things you had to do regarding work, school, or your home?), and their interference with social 
life (During the last week, to what extent has depression interfered with your social life and your 
relationships?). The third item of the OASIS and ODSIS differs, however. In the OASIS, this item 
evaluates the presence of avoidant behavior (During the last week, how often have you avoided 
situations, places, objects, or activities because of your anxiety or fear?), whereas the ODSIS 
measures the loss of interest or difficulty in participating in activities (During the last week, how often 
have you had difficulty to carry out or feel interest in activities that you normally enjoy because of 
your depression?). Items in the ODSIS use a 5 point Likert response scale ranging from 0 (I didn't feel 
depressed) to 4 (Constant depression). Again, total scores range from 0 to 20 after summing all items, 
with higher values revealing a more severe and functional impairment as a result of depressive 
symptoms (Bentley et al., 2014). As with the OASIS, we used the same process to translate the 
Spanish version of the ODSIS, which can be found in Appendix 1. Like with the OASIS, the 
Cronbach’s alpha value for the ODSIS in the present sample is presented in the results section. 
Data analysis 
Demographic and sex differences in study variables 
Analyses were carried out using the statistical package IBM SPSS Statistics version  
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22.0 for Windows (IBM Corp., 2013) and Mplus version 6 program (Muthen & Muthen, 1998). 
Firstly, sociodemographic characteristics of the total sample were analyzed (N = 339), as well as the 
means and standard deviations for all measures. Next, sex differences in the OASIS and the ODSIS 
were investigated. Because scores in men and women were not normally-distributed (Kolmogorov-
Smirnov normality test), a Mann-Whitney non-parametric U-test was selected for this analysis.  
Model fit, internal consistency, and convergent and discriminant validity  
Next, we investigated the internal structure and the convergent and discriminant validity of the OASIS 
and the ODSIS. The internal structure of the OASIS and the ODSIS were calculated with a 
Confirmatory Factor Analysis (CFA). Because we had no missing data, we were able to use a 
maximum likelihood estimator with standard errors and a mean-adjusted chi-square test statistic that 
are robust to non-normality (MLM). The one-factor model fit was evaluated with the Satorra-Bentler 
robust Chi-square test, the root mean square error of approximation (RMSEA), the comparative fit 
index (CFI), the Tucker-Lewis index (TLI), and the standardized root mean square residual  
(SRMR). RMSEA and SRMR scores below .05 indicate good model fit and values below  
.08 reflect acceptable fit. CFI and TLI scores above .95 reveal an excellent fit (Hu & Bentler,  
1999). The convergent and discriminant validity of the OASIS and the ODSIS was explored by 
calculating their Pearson correlations with well-established measures of anxiety (BAI) and depression 
(BDI-II), respectively. To test the hypothesis that the OASIS would be more strongly associated with 
the BAI and the ODSIS would correlate more with the BDI, the strength of these bivariate associations 
was compared using the cocor R package (Diedenhofen & Musch, 2015). Pearson correlations with 
several constructs closely related to anxiety and depressive symptoms (i.e., personality, affect, quality 
of life, and adjustment) were also conducted to investigate the convergent and discriminant validity of 
the OASIS and ODSIS. Specifically, the correlation between the aforementioned related constructs 
and the OASIS and the ODSIS are expected to be significant (i.e., a positive association with 
neuroticism, negative affect, and maladjustment, and a negative correlation with extraversion, positive 
affect, and quality of life or similar constructs), but smaller when compared to the correlation between 
the OASIS and the ODSIS with the BAI and the BDI-II (e.g., Campbell-Sills et al., 2009; Ito et al., 
2015).  
Optimal cut-offs and sensitivity to change 
As a final step, we calculated the optimal cut-off points for the two aforementioned scales using a 
ROC curve analysis, as well as their sensitivity to capture therapeutic change. In relation to the former 
goal, sensitivity and specificity were investigated for several cut-offs, following the guidelines of 
Zweig and Campbell (1993). Positive and negative predictive values and likelihood ratios were also 
investigated. The sensitivity and specificity, as well as the positive and negative predictive values and 
likelihood ratios of the OASIS and the ODSIS were calculated in relation to the BAI and BDI-II, 
respectively. The BAI and BDI-II cut-offs used to classify individuals as severely anxious and 
depressed were 16 and 20, respectively (Sanz, 2014; Sanz et al., 2003). Regarding sensitivity to 
therapeutic change, we first calculated variables for the OASIS, the ODSIS, the BAI, and the BDI-II 
by subtracting the total score after treatment from the total score prior to treatment. Next, Pearson 
correlations between OASIS and BAI, and ODSIS and BDI-II, respectively, change scores were 
conducted. Also, we calculated Cohen’s d effect size to help interpret the findings. This analysis was 
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carried out with the subsample of participants (n = 219) that participated in two assessment points 
(pre-treatment and post-treatment). 
Results 
As observed in Table 1, the most frequent primary diagnoses in the sample (N=339) were adjustment 
disorders (n=77, 22.7%), followed by major depressive disorders (n=62, 18.3%), and generalized 
anxiety disorders (n=43, 12.7%). Ninety nine participants (26.8%) also had a secondary diagnosis, of 
which major depressive disorder (n=19, 19.2%) and non-specific anxiety disorder (n=14, 14.1%) were 
the most frequent. 
Table 2 shows the mean scores and standard deviations for all instruments. The average score for the 
OASIS and the ODSIS was 10.45 (SD = 4.49, range 0-20) and 9.87 (SD = 5.14, range 0-20), 
respectively.  
Model fit, internal consistency, convergent and discriminant validity, optimal cut-offs, and sensitivity to 
change of the OASIS 
As reported in past research, the error variances of items 1 and 2 in the OASIS need to be correlated 
for adequate fit. This was also true in the present study. When item 1 and 2 were not correlated, a poor 
fit was revealed (χ2 (5, 303) = 55.62, p< .001; RMSEA = 0.183, 90% RMSEA = 0.141-0.228; CFI = 
0.926; TLI = 0.853; SRMR = 0.054).When item 1 and 2 were correlated, as indicated in previous 
research (Campbell-Sills et al., 2009), the fit clearly improved (χ2 (4, 303) = 2.49, p=.646; RMSEA < 
0.001, 90% RMSEA = <0.001-0.070; CFI = 1.000; TLI = 1.000; SRMR = 0.011). Factor loadings 
were between moderate and large and all significant at an alpha level of .001 (Table 3). 
The analysis of internal consistency indicated good reliability of the OASIS (α =  
.867). Table 2 also reports the results of the convergent and discriminant validity of the OASIS, as 
reflected by Pearson correlations. With regard to convergent and discriminant validity, the OASIS 
correlated moderately both with the BAI (r = .57, p < .001), and the BDI-II (r = .60, p < .001). 
According to the results obtained with the cocor R package, both correlations were comparable in 
strength (the 95% CI for the difference includes zero: -.0964, 0.0356). The OASIS and the ODSIS 
clearly correlated with each other (r = .69, p < .001).  Taking the criterion validity of the OASIS, 
positively the scale correlated positively with a measure of neuroticism (r = .43), maladjustment (r = 
.57), and negative affect (r = .49), and were negatively associated with a measure of extraversion (r = -
.30), quality of life (r = -.57), and positive affect (r = -.34).  
All correlations were significant at an alpha level of .001.  
The final analyses for the OASIS included an exploration of its optimal cut-off points, followed by an 
analysis of its sensitivity to change. In relation to the former, the ROC analysis indicated an area under 
the curve of .83 when predicting moderate-to-severe anxiety as measured with the BAI (95% CI = .78, 
.88). We considered 10 to be the best cut-off point to discriminate between people who had moderate-
to-severe anxiety symptoms and those with milder or no symptoms because of the good balance 
between sensitivity (.75) and specificity (.73). With this cut-off point, 74.9% of correct classifications 
were reached (Youden Index of .49). Positive and negative predictive values were 91.4% and 38.8%, 
respectively. Positive and negative likelihood ratios were 2.8 and 0.3, respectively. The analysis of 
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sensitivity to change (n = 219) revealed a correlation of .40 (p< .001) between the BAI and the 
OASIS. Cohen’s d effect size was .50, showing moderate differences between assessments. 
Model fit, internal consistency, convergent and discriminant validity, optimal cut-offs, and sensitivity to 
change of the ODSIS 
Like in the OASIS, research with the ODSIS has indicated that the error variances of items 1 and 2 
need to be correlated for adequate fit. We obtained the same results. Specifically, when item 1 and 2 
were not correlated, a poor fit was obtained (χ2 (5, 303) = 55.27, p< .001; RMSEA = 0.182, 90% 
RMSEA = 0.141-0.227; CFI = 0.957; TLI = 0.914; SRMR = 0.031). On the contrary, when item 1 and 
2 were correlated, the fit clearly improved (χ2 (4, 303) = 2.46, p= .653; RMSEA < .001, 90% RMSEA 
= <0.001-0.069; CFI = 1.000; TLI = 1.000; SRMR = 0.007). Factor loadings were large and 
significant at an alpha level of .001 (Table 3). 
Similar to the OASIS, the analysis of internal consistency indicated excellent reliability of the ODSIS 
(α = .936). The results of the convergent and discriminant validity of the ODSIS are reported on Table 
2. The ODSIS correlated moderately with the BDI-II (r = .68, p < .001) and weakly with the BAI (r = 
.42, p < .001). Different to the results obtained with the OASIS, the analyses indicated differences in 
strength between the aforementioned correlations (the 95% CI for the difference did not include 
zero:.1919, 0.3335). In the assessment of criterion validity, the ODSIS was found to positively 
correlate with a measure of neuroticism (r = .43), maladjustment (r = .58), and negative affect (r = 
.42), and were negatively associated with a measure of extraversion (r = -.33), quality of life (r = -.64), 
and positive affect (r = -.48). All correlations were significant at an alpha level of .001. 
We next explored the optimal cut-off value in the ODSIS to discriminate individuals with moderate-
to-severe depressive symptoms in the BDI-II from those with milder or no symptoms. The ROC 
analysis indicated an area under the curve of .83 (95% CI = .78, .87). Again, a cut-off of 10 was 
considered to provide an adequate balance between sensitivity (.74) and specificity (.79). Using this 
cut-off score, 75.2% of individuals were correctly classified (Youden Index of .53). Positive and 
negative predictive values were 91.7% and 48.4%, respectively. Positive and negative likelihood ratios 
were 3.5 and 0.3, respectively. Finally, the analysis of sensitivity to change (n = 219) indicated a 
correlation of .56 (p < .001) between the BDI-II and the ODSIS. Cohen’s d effect size was .73, 
showing moderate differences between both evaluations. 
Discussion 
This is the first study to explore the psychometric properties of the OASIS and ODSIS in a Spanish 
sample of patients diagnosed with ED in a specialized mental health setting, and, consequently, the 
contributions made are innovative and necessary.  
The results regarding the internal structure of the OASIS and the ODSIS, as obtained with the CFA, 
are consistent with other studies and indicate that a one-factor structure for the five items has an 
optimal fit (Bentley et al., 2014; Bragdon et al., 2016; Campbell-Sills et al., 2008; Hermans et al., 
2014; Ito et al., 2014; Ito et al., 2014; Moore et al., 2015; Norman et al., 2013; Norman et al., 2011; 
Norman et al., 2006).The present study revealed that the influence of the covariance between Items 1 
and 2 has to be taken into account when exploring the internal structure of the OASIS and the ODSIS, 
as noted in previous similar studies (Campbell-Sills et al., 2009). As revealed in the present 
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investigation, the reason for this is that the absence of anxious or depressive symptoms (score of 0 on 
Item 1) unequivocally leads to a score of 0 on Item 2 (intensity), so the items are dependent on each 
other. 
Data from the present study suggests that a cut-off point of 10 for both instruments results in the best 
rate of correct clinical/non-clinical classifications (72.5% of correct classifications in the OASIS and 
75.2% in the ODSIS), which is different to the value proposed by some previous investigations (e.g., 
Hermans et al., 2014; Norman et al., 2013). Both validation studies proposed cut-offs of 5 in clinical 
samples, with 82.5% and 91% of correct classifications respectively. As noted by these authors, the 
different cut-off points proposed tend to be attributable to the particular characteristics of their 
samples (% of women and men, variety of EDs, and % comorbidity disorders in the sample, among 
others) and the setting where the studies were conducted (mental health settings or community 
services). The previous might also explain why our recommended cut-off values are also higher than 
those indicated in a recent Spanish validation of the online version of the OASIS in a subclinical 
sample with ED, where a cut-off of 7.5 was proposed (González-Robles et al., 2018). These 
differences could be, at least partly, attributable to the differences in the samples and the evaluation 
methods used in the investigations (i.e., individuals who attended a University clinic online version of 
the questionnaire in the study by González-Robles, as opposed to patients who attended public mental 
health settings and answered to the questionnaires on a paper and pencil version in our study. In favor 
of this conclusion, we observed that anxiety and depressive symptoms were more severe in the present 
study when compared to the investigation by González-Robles and colleagues (2018). Specifically, 
mean scores in our sample were significantly higher in the OASIS (t = 5.78, p < .001), the ODSIS (t = 
6.21, p < .001), the BAI (t = 7.52, p < .001), and the BDI-II (t = 5.16, p < .001) when compared to the 
aforementioned investigation in Spanish settings.  
Because sample characteristics are important factors in the determination of cut-off scores, we will 
now discuss our findings in relation to investigations including a sample of outpatients presenting a 
primary diagnosis of ED, similar to the present study. Our proposed cut-off point for the OASIS is the 
same as the one suggested by Bragdon and colleagues (2016), who with obtained a 76% of correct 
classifications with a cut-off of 10, and also close to the recommendation of Ito and colleagues (2015), 
who proposed a cut-off score of 9 with 68% of correct classifications. Somewhat lower cut-off values 
have also been proposed, including the work of Campbell-Sills and colleagues (2009), Moore and 
colleagues (2015), and Norman and colleagues (2011), who recommended a cut-off point of 8 for the 
OASIS, with a percentage of correct classifications of 87%, 67%, and 78%, respectively. Regarding 
the ODSIS, our results are similar to those obtained by Bentley and colleagues (2014) and Ito et al. 
(2015), who recommended a cut-off point of 8 (82% correct classifications) and 11 (82.3% of correct 
classifications), respectively. What these different cut-off scores indicate is that validation and 
replication studies, such as the present, are important to increase the reliability of findings across 
settings and countries.   
The Cronbach alphas of the two instruments (.87 for OASIS and .94 for the ODSIS) demonstrate 
excellent internal consistency. These scores fall within the range (.80 ≤ α ≤ .96) observed in the 
literature (Bentley et al., 2014; Bragdon et al., 2016; Campbell-Sills et al., 2008; Hermans et al., 2014; 
Ito et al., 2014; Moore et al., 2015; Norman et al., 2013; Norman et al., 2011; Norman et al., 2006), 
suggesting that the items were well validated and adequately understood by this study participants. 
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Results on the convergent and discriminant validity of the OASIS and the ODSIS were also 
satisfactory. The correlations between both measures and the remaining instruments were significant 
and in the expected directions. At this stage, it is important to note that, contrary to our expectations, 
the OASIS did not correlate stronger with a measure of anxiety (BAI) than with the measure of 
depression (BDI-II). This result may be due to high rates of comorbidity between these two constructs 
(Brown & Barlow, 2009). However, the correlations between the ODSIS and the BDI-II and the BAI 
were consistent with our expectations (i.e., stronger for the BDI-II), so another possibility is that 
people with a primary diagnosis of an anxiety disorder perhaps did not meet criteria for a diagnosis of 
depression, but presented high scores on depression symptoms. In fact, comorbitidy of symptoms in 
our sample was evident. For instance, note that the 209 participants (61.7% of the sample) who 
presented moderate or severe scores on the BAI, also presented moderate or severe scores on the BDI-
II. 
In the evaluation of sensitivity to therapeutic change, both changes in the OASIS and the ODSIS 
moderately correlated with changes with the BAI and the BDI-II, respectively.  These findings suggest 
that both instruments can capture changes in anxious and depressive symptoms after cognitive-
behavioral treatment. This analysis was also performed in the study of Norman and colleagues (2013) 
for the OASIS, with a sample of women who had been victims of partner violence. Their results also 
showed positive correlations with the reference measures, namely the Anxiety subscale of the Brief 
Symptom Inventory (BSI-18; Derogatis & Melisaratos, 1983) and the Clinician Administered Post-
Traumatic Stress Disorder Scale for DSM-IV (CAPS; Blake et al., 1995). They found that the change 
scores in the OASIS correlated highly with change scores in both the CAPS (r=.64, p<.01) and the 
BSI-Anxiety (r=.92, p<.001). The authors noted that future studies should examine sensitivity to 
change of the measures in a sample that also included men and higher diagnostic variability, both of 
which we have addressed in the present study.  
The present study is not without limitations. First, only a subsample of participants provided data for 
all assessment points, so the sensitivity to therapeutic change could only be calculated in a subset of 
participants. It would be interesting to replicate these analyses using a larger sample. Another 
limitation is that the distribution of the sex was not homogeneous, as women were more frequently 
represented in the sample. While this might have influenced the present investigation results, it should 
be noted that the prevalence of women with ED is significantly higher than that of men (WHO, 2017), 
so the study findings are actually representative of the distribution of EDs in the general population 
and therefore might be useful for general practice. Another shortcoming was that inter-rater reliability 
of diagnoses could not be investigated. This had implications, as the sensitivity to change could not be 
examined against diagnoses based on structured clinical interviews due to the inability to test their 
reliability. In addition, we were not able to analyze the test-retest reliability because all participants 
were enrolled in a research clinical trial about the efficacy and feasibility of the UP for transdiagnostic 
treatment of ED, which would affect the stability of scores (Blinded). It is also important to note that 
the cut-off points for the OASIS and the ODSIS were calculated according to the established cut-offs 
for the BAI and BDI-II, as opposed to using a sample of healthy controls and instead of using a 
clinical-based criterion. While the BAI and the BDI-II are well-established screening tools, the 
possibility that these measures introduce some bias in diagnosis should not be ignored and the 
combination of self-reports and clinical-based criteria should be addressed in future research. Finally, 
the cut-offs proposed in this study are based on a sample of people seeking treatment for ED in a 
specialized mental care in Spain and included patients with a primary ED diagnosis, so the findings 
may not be generalizable to other settings. 
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Conclusions 
This study adds to the growing literature supporting the validity of the OASIS and ODSIS as 
screening tools for anxiety and mood disorders. It also provides data about their sensitivity to change 
after a psychological treatment, which makes them useful tools to be included in routine care to 
rapidly assess the effectiveness of interventions. Additionally, this investigation provides further 
evidence for the utility of both scales in a new country, namely, Spain. 
The validation of the OASIS and the ODSIS in Spanish offers large potential benefits to public health 
services. First, the OASIS and ODSIS are easily administered screening tools with adequate 
psychometric properties, allowing practitioners to detect, in just three minutes, individuals who 
present anxious or depressive symptomatology. In addition, because these scales do not require 
specialized training for their application, the OASIS and ODSIS may help family physicians to make 
important decisions, such as referring a person who needs specialized care. In to the case of mental 
health professionals working in specialized care, these scales can be useful to monitor the evolution of 
anxiety and depression symptoms over the course treatment in a quickly and easy way.  
In conclusion, the OASIS and ODSIS have the potential to help improve patients’ mental health on a 
scalable level, facilitating specialized, efficient, and prompt care for those who need it.  
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Appendix 1 
Both scales have been reprinted from Barlow, D. H., Sauer-Zavala, S., Farchione, T. J., Murray, H., Ellard, K., 
Bullis, J.,…Cassiello-Robbins, C. (2018). Unified Protocol for Transdiagnostic Treatment of Emotional Disorders 
(2nded.) [Protocolo Unificado para el Tratamiento Transdiagnóstico de los Trastornos Emocionales (2.ª ed.), 
traducida por Jorge Osma y Elena Crespo)]. Madrid: Alianza Editorial, 2019. 
Escala General de Gravedad e Interferencia de Ansiedad 
Los siguientes ítems preguntan sobre ansiedad. Para cada ítem, rodee el número que mejor describa su experiencia durante 
la última semana. 
1. Durante la última semana, ¿con qué frecuencia te has sentido ansioso? 
 • = No me sentí ansioso durante la última semana. 
 • = Ansiedad infrecuente. Me sentí ansioso en algunos momentos. 
 • = Ansiedad ocasional. La mitad del tiempo me sentí ansioso y la otra mitad no. Me costó 
relajarme. 
 • = Ansiedad frecuente. Me sentí ansioso la mayor parte del tiempo. Me resultó muy difícil 
relajarme. 
 • = Ansiedad constante. Me sentí ansioso todo el tiempo y nunca llegué a relajarme. 
2. Durante la última semana, cuando te sentiste ansioso, ¿cómo de intensa o grave fue tu ansiedad? 
 • = Poco o nada. La ansiedad estuvo ausente o casi no la noté.  
 • = Leve. La ansiedad fue de baja intensidad. Pude relajarme cuando lo intenté. Los síntomas 
físicos fueron solo un poco molestos. 
 • = Moderada. La ansiedad me generó malestar en algunos momentos. Me resultó difícil relajarme 
o concentrarme, pero pude hacerlo cuando lo intenté. Los síntomas físicos fueron molestos. 
 • = Severa. La ansiedad fue intensa la mayor parte del tiempo. Me resultó muy difícil relajarme o 
concentrarme en cualquier otra cosa. Los síntomas físicos fueron enormemente molestos. 
 • = Extrema. La ansiedad me sobrepasó. Me fue totalmente imposible relajarme. Los síntomas 
físicos fueron insoportables. 
3. Durante la última semana, ¿con qué frecuencia evitaste situaciones, lugares, objetos o actividades debido a tu 
ansiedad o miedo? 
 • = Ninguna. No evité lugares, situaciones, actividades o cosas por miedo. 
 • = Infrecuente. Evité algunas cosas de vez en cuando, pero por lo general me enfrenté a las 
situaciones u objetos. Mi estilo de vida no se vio afectado. 
 • = Ocasional. Tuve algo de miedo a ciertas situaciones, lugares u objetos, pero todavía pudo 
manejarlos. Mi estilo de vida sufrió pocos cambios. Siempre o casi siempre evité las cosas que me dan miedo si 
estaba solo, pero las pude manejar si alguien venía conmigo. 
 • = Frecuente. Tuve bastante miedo y realmente intenté evitar las cosas que me asustan. He hecho 
cambios significativos en mi estilo de vida para evitar objetos, situaciones, actividades o lugares. 
 • = Todo el tiempo. Evitar objetos, situaciones, actividades o lugares ha ocupado gran parte de mi 
vida. Mi estilo de vida se ha visto enormemente afectado y ya no hago cosas con las que solía disfrutar. 
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4. Durante la última semana, ¿en qué medida ha interferido la ansiedad en tu capacidad para hacer las cosas que 
necesitabas hacer en el trabajo, el colegio o en  tu hogar? 
 • = Nada. La ansiedad no interfirió en mi trabajo/hogar/colegio. 
 • = Leve. La ansiedad me causó algo de interferencia en mi trabajo/hogar/colegio. Las cosas eran 
más difíciles, pero pude realizar todo lo que necesitaba hacer. 
 • = Moderada. La ansiedad definitivamente interfirió en mis tareas. He podido realizar la mayoría 
de las cosas, pero solo algunas las he hecho tan bien como en el pasado. 
 • = Severa. La ansiedad verdaderamente ha cambiado mi capacidad para hacer las cosas. Algunas 
cosas las he podido realizar, pero otras no. Mi rendimiento se ha visto definitivamente afectado. 
 • = Extrema. La ansiedad ha llegado a ser incapacitante. He sido incapaz de completar mis tareas y 
he tenido que irme del colegio, he dejado o me han despedido de mi trabajo o he sido incapaz de completar las 
tareas del hogar y he sufrido consecuencias como desalojos, cobradores de facturas, etc. 
5. Durante la última semana, ¿en qué medida ha interferido la ansiedad en tu vida social y en tus relaciones? 
 • = Nada. La ansiedad no interfirió en mis relaciones. 
 • = Leve. La ansiedad apenas interfirió en mis relaciones. Algunas de mis amistades y otras 
relaciones se han visto afectadas, pero en conjunto mi vida social sigue siendo satisfactoria. 
 • = Moderada. La ansiedad interfirió algo en mi vida social, pero sigo teniendo algunas relaciones 
cercanas. No paso tanto tiempo con otros como en el pasado, pero sigo teniendo relaciones sociales algunas veces. 
 • = Severa. Mis amistades y otras relaciones se han visto muy afectadas a causa de mi ansiedad. 
No disfruto de las actividades sociales. Tengo muy pocas relaciones sociales. 
 • = Extrema. La ansiedad ha alterado completamente mis actividades sociales. Todas mis 
relaciones se han visto afectadas o han finalizado. Mi vida familiar es extremadamente tensa. 
Puntuación total: ____ 
Escala General de Gravedad e Interferencia de Depresión 
Los siguientes ítems preguntan sobre depresión. Para cada ítem, rodee el número que mejor describa su experiencia durante 
la última semana. 
 
1. Durante la última semana, ¿con qué frecuencia te has sentido deprimido? 
 • = No me sentí deprimido durante la última semana. 
 • = Depresión infrecuente. Me sentí deprimido en algunos momentos. 
 • = Depresión ocasional. La mitad del tiempo me sentí deprimido y la otra mitad no.  
 • = Depresión frecuente. Me sentí deprimido la mayor parte del tiempo.  
 • = Depresión constante. Me sentí deprimido todo el tiempo. 
2. Durante la última semana, cuando te sentiste deprimido, ¿cómo de intensa o grave fue tu depresión? 
 • = Poco o nada. La depresión estuvo ausente o casi no la noté. 
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 • = Leve. La depresión fue de baja intensidad.  
 • = Moderada. La depresión me generó malestar en algunos momentos.  
 • = Severa. La depresión fue intensa la mayor parte del tiempo.  
 • = Extrema. La depresión me sobrepasó.  
3. Durante la última semana, ¿con qué frecuencia tuviste dificultad para realizar o interesarte en actividades que 
normalmente disfrutas debido a tu depresión? 
 • = Ninguna. No tuve dificultades para realizar o interesarme en actividades que normalmente 
disfruto debido a la depresión. 
 • = Infrecuente. Algunas veces tuve dificultades para realizar actividades o interesarme en 
actividades que normalmente disfruto, debido a la depresión. Mi estilo de vida no se vio afectado. 
 • = Ocasional. Tuve algunas dificultades para realizar actividades o interesarme en actividades que 
normalmente disfruto, debido a la depresión. Mi estilo de vida sufrió pocos cambios.  
 • = Frecuente. Tuve bastantes dificultades para realizar actividades o interesarme en actividades 
que normalmente disfruto, debido a la depresión. He realizado cambios significativos en mi estilo de vida por no 
poder interesarme en actividades que solía disfrutar. 
 • = Todo el tiempo. No he podido participar o interesarme en actividades que normalmente 
disfruto, debido a la depresión. Mi estilo de vida se ha visto enormemente afectado y ya no hago cosas que solía 
disfrutar. 
4. Durante la última semana, ¿en qué medida ha interferido la depresión en tu capacidad para hacer las cosas que 
necesitabas hacer en el trabajo, el colegio o en  tu hogar? 
 • = Nada. La depresión no interfirió en mi trabajo/hogar/colegio. 
 • = Leve. La depresión me causó algo de interferencia en mi trabajo/hogar/colegio. Las cosas 
fueron más difíciles, pero pude realizar todo lo que necesitaba hacer. 
 • = Moderada. La depresión definitivamente interfirió en mis tareas. He podido realizar la mayoría 
de las cosas, pero solo algunas las he hecho tan bien como en el pasado. 
 • = Severa. La depresión verdaderamente ha interferido en mis tareas. Algunas tareas las he podido 
realizar, pero muchas otras no. Mi rendimiento se ha visto definitivamente afectado. 
 • = Extrema. La depresión ha llegado a ser incapacitante. He sido incapaz de completar mis tareas 
y he tenido que irme del colegio, he dejado o me han despedido de mi trabajo o he sido incapaz de completar las 
tareas del hogar y he sufrido consecuencias como desalojos, cobradores de facturas, etc. 
5. Durante la última semana, ¿en qué medida ha interferido la depresión en tu vida social y en tus relaciones? 
 • = Nada. La depresión no interfirió en mis relaciones. 
 • = Leve. La depresión apenas interfirió en mis relaciones. Algunas de mis amistades y otras 
relaciones se han visto afectadas, pero en conjunto mi vida social sigue siendo satisfactoria. 
 • = Moderada. La depresión ha interferido algo en mi vida social, pero sigo teniendo algunas 
relaciones cercanas. No paso tanto tiempo con otros como en el pasado, pero sigo manteniendo relaciones sociales 
algunas veces. 
 • = Severa. Mis amistades y otras relaciones se han visto muy afectadas a causa de mi depresión. 
No disfruto de las actividades sociales. Tengo muy pocas relaciones sociales. 
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 • = Extrema. La depresión ha alterado completamente mis actividades sociales. Todas mis 
relaciones se han visto afectadas o han finalizado. Mi vida familiar es extremadamente tensa. 
Puntuación total:  
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Figure 1       
 
ROC curve for the OASIS    ROC curve for the ODSIS 
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Table 1 
Socio-demographic Characteristics of Participants (N = 339) 
 Participants with one 
evaluation 
n (%) 
Participants with 
two evaluations 
n (%) 
χ² p 
Educational level 120 (35.4) 219 (64.6) 0.991 .319 
Less than 12 years of education received 51 (42.5) 81 (37.0)   
No studies 2 (1.7) 5 (2.3)   
Primary studies 24 (20.0) 38 (17.4)   
Secondary studies 25 (20.8) 38 (17.4)   
More than 12 years of education received 69  (57.5) 138 (63.0)   
High school 9 (7.5) 28 (12.8)   
Vocational training 23 (19,2) 62 (28,3)   
University studies 37 (30.8) 48 (21.9)   
Marital status 120 (35.4) 219 (64.6) 3.554 .059 
Married/living w partner 48 (40.0) 111 (50.7)   
Not Married/not living w partner 72 (60.0) 108 (49.3)   
Single 51 (42.5) 67 (30.6)   
Separated/ Divorced 17 (14.2) 36 (16.4)   
Widowed 4 (3.3) 5 (2.3)   
Job status 120 (35.4) 219 (64.6) 1.968 .161 
Working 56(46.7) 85 (38.8)   
Non-working 64 (53.3) 134 (61.2)   
Unemployed 26 (21.7) 52 (23.7)   
Sick leave 15 (12.5) 44 (20.1)   
Student 14 (11.7) 12 (5.5)   
  Home-maker 3 (2.5) 20 (9.1)   
Retiree 6 (5.0) 6 (2.7)   
Primary diagnosis 120 (35.4) 219 (64.6) 3.984 .136 
Anxiety disorders 65 (54.2) 102 (46.6)   
Generalized anxiety disorder 17 (14.2) 26 (11.9)   
Panic disorder with agoraphobia 22 (18.3) 13 (5.9)   
Non-specific anxiety disorder 4 (3.3) 15 (6.8)   
Panic disorder without agoraphobia 5 (4.2) 12 (5.5)   
Agoraphobia 7 (5.8) 8 (3.7)   
Obsessive-compulsive disorder 2 (1.7) 10 (4.6)   
Social phobia 5 (4.2) 5 (2.3)   
Posttraumatic stress disorder 1 (.8) 6 (2.7)   
Hypochondria 2 (1.7) 4 (1.8)   
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Specific phobia 0 (.0) 3 (1.4)   
Mood disorders 35 (29.2) 60 (27.4)   
Major depressive disorder 22 (18.3) 40 (18.3)   
Dysthymia 12 (10.0) 11 (5.9)   
Unspecified mood disorder 1 (.8) 9 (4.1)   
Mixed disorders 20 (16.7) 57 (26.9)   
Adjustment disorder 20 (16.7) 57 (26.9)   
Secondary diagnosis  37 (10.9) 62  (18.3) 3.159 .206 
Anxiety disorders 25 (20.8) 40 (18.3)   
Non-specific anxiety disorder 3 (2.5) 11 (5.0)   
Obsessive-compulsive disorder 5 (4.2) 5 (2.3)   
Generalized anxiety disorder 2 (1.7) 6 (2.7)   
Social phobia 4 (3.3) 3 (1.4)   
Panic disorder without agoraphobia 2 (1.7) 4 (1.8)   
Agoraphobia 4 (3.3) 2 (.9)   
Specific phobia 2 (1.7) 3 (1.4)   
Hypochondria 0 (0.0) 4 (1.8)   
Panic disorder with agoraphobia 1 (.8) 2 (.9)   
Posttraumatic stress disorder 2 (1.7) 0 (.0)   
Mood disorders 8 (6.7) 20 (9.1)   
Major depressive disorder 7 (5.8) 12 (5.5)   
Dysthymia 1 (.8) 8 (3.7)   
Mixed disorders 4 (.3) 2 (.9)   
Adjustment disorder 3 (2.5) 2 (.9)   
Somatoform disorder 1 (.8) 0 (.0)   
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Table 2 
Correlations between the OASIS and the ODSIS and Measures of Convergent and Discriminant Validity and internal consistency estimates 
 M (SD) Min - Max OASIS ODSIS BAI BDI-II NEO-FFI 
N 
NEO-FFI 
E QLI SM 
PANAS 
POS 
PANAS 
NEG 
OASIS 10.45 (4.49) 0 - 20 (.87) .69** .57** .60** .43** -.30** -.57** .57** -.34** .49** 
ODSIS 9.88 (5.14) 0 - 20 · (.94) .42** .68** .43** -.33** -.64** .58** -.48** .42** 
BAI 26.81 (13.36) 0 - 63 · · (.93) .53** .42** -.20** -.43** .41** -.20** .50** 
BDI-II 27.60 (12.12) 0 - 63 · · · (.92) .50** -.40** -.69** .63** -.49** .53** 
NEO-FFI N 31.64 (7.62) 0 - 48 · · · · (.76) -.34** -.45** .43** -.33** .56** 
NEO-FFI E 22.70 (8.01) 0 - 48 · · · · · (.81) .48** -.35** .46** -.19** 
QLI 46.05 (16.06) 0 - 100 · · · · · · (.87) -.64** .51** -.40** 
SM 18.09 (6.33) 0 - 30 · · · · · · · (.83) -.36** .41** 
PANAS-POS 20.72 (6.90) 10 - 50 · · · · · · · · (.89) -.16** 
PANAS-NEG 28.49 (8.72) 10 - 50 · · · · · · · · · (.89) 
Note: OASIS: Overall Anxiety Severity and Impairment Scale; ODSIS: Overall Depression Severity and Impairment Scale; BAI: Beck Anxiety Inventory; BDI-
II: Beck Depression Inventory; NEO-FFI N: NEO-Five-Factor Personality Inventory Neuroticism; NEO-FFI E: NEO-Five-Factor Personality Inventory 
Extraversion; QLI: Quality of Life Index; SM: Scale of Maladjustment; PANAS POS: Positive and Negative Affect Scale- Positive; PANAS NEG: Positive and 
Negative Affect Scale- Negative. Minimum and maximum scores correspond to direct scale scores. Scale reliability corresponds to the Cronbach’s alpha 
coefficient and is presented in parentheses. *p < .01 **p < .001 
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Table 3 
Factor Loadings with the 5-Factor Model without Correlating the Error  
Variance for the OASIS 
Item Description Factor loading 
  OASIS ODSIS 
1 Frequency of symptoms .62 .82 
2 Intensity of symptoms .68 .81 
3 Degree of avoidance/ loss of interest .68 .90 
4 Interference in work, school life .89 .88 
5 Interference in social life .86 .86 
In all cases, p < .001. 
 
 
 
 
 
 
 
 
 
 
